QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Identification of SARS-CoV-2 entry inhibitors among already approved drugs 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 7 作者:  Yang, Li;  Pei, Rong-juan;  Li, Heng;  Ma, Xin-na;  Zhou, Yu 收藏  |  浏览/下载：42/0  |  提交时间：2020/12/24 COVID-19  SARS-CoV-2  virus entry inhibitors  high throughput screening assay  approved drug library  histamine receptor antagonists  clemastine   Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML) 期刊论文 CANCER BIOLOGY & THERAPY, 2019, 卷号: 20, 期号: 6, 页码: 877-885 作者:  Wu, Jiaxin;  Wang, Aoli;  Li, Xixiang;  Chen, Cheng;  Qi, Ziping 收藏  |  浏览/下载：29/0  |  提交时间：2019/11/27 BCR-ABL  PDGFR  chronic myeloid leukemia  kinase inhibitor   SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-small-cell Lung Cancer (NSCLC) and Erlotinib-Resistant NSCLC 期刊论文 FRONTIERS IN ONCOLOGY, 2019, 卷号: 9 作者:  Yuan, Man;  Xu, Lin-feng;  Zhang, Juan;  Kong, Si-yuan;  Wu, Man 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 non-small-cell lung cancer  MEK and SRC inhibitor  trametinib  bosutinib  synergistic effect   AXL小分子抑制剂的设计、合成及抗肿瘤活性研究 学位论文 广州生物院: 中国科学院大学, 2016 作者:  谈理 收藏  |  浏览/下载：30/0  |  提交时间：2018/12/25 AXL受体  TAM酪氨酸激酶  肿瘤侵袭和迁移  选择性抑制剂   Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer 期刊论文 2014, 卷号: 19, 期号: 4, 页码: 348-349 作者:  Moy, Beverly;  Neven, Patrick;  Lebrun, Fabienne;  Bellet, Meritxell;  Xu, Binghe 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer 期刊论文 2014, 卷号: 19, 期号: 4, 页码: 346-347 作者:  Moy, Beverly;  Neven, Patrick;  Lebrun, Fabienne;  Bellet, Meritxell;  Xu, Binghe 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 Bosutinib and exemestane (EXE) versus EXE alone in postmenopausal (postm) women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (ABC). 期刊论文 2011, 卷号: 29, 期号: 15 作者:  Moy, B.;  Lebrun, F.;  Bellet, M.;  Chow, L.;  Lang, I. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Bosutinib (BOS) and letrozole (LET) versus LET alone as firstline treatment in postmenopausal women with advanced breast cancer (ABC) 期刊论文 2011, 卷号: 29, 期号: 15 作者:  Chow, L.;  Xu, B.;  Dirix, L. Y.;  Moy, B.;  Leip, E. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13